AU Patent

AU2021208129A1 — Pharmaceutical composition of tricyclic PDE3/PDE4 dual inhibitor compound

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2022-08-18 · 4y expired

What this patent protects

A pharmaceutical composition of a tricyclic PDE3/PDE4 dual inhibitor compound and a preparation method therefor, specifically relating to a pharmaceutical composition of a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation method therefor, and us…

USPTO Abstract

A pharmaceutical composition of a tricyclic PDE3/PDE4 dual inhibitor compound and a preparation method therefor, specifically relating to a pharmaceutical composition of a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation method therefor, and use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021208129A1
Jurisdiction
AU
Classification
—
Expires
2022-08-18
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.